Bio-Rad Releases First FDA-Cleared Liquid Biopsy Test for Chronic Myeloid Leukemia
Using the kit, clinicians can accurately and reproducibly monitor residual disease in patients with chronic myeloid leukemia, even at low levels.
Read More
Search Results for: leukemia
Study Results Guide Anti-CMV Treatment after Stem Cell Transplantation
Continued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.
Read More
FDA Grants Clearance for OGT’s AML/MDS FISH Probes
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.
Read More
National Cancer Institute Grants Support Liquid Biopsy Studies
With three NCI grants, BioFluidica is investigating chip-based liquid biopsy technologies for the detection of cancer and related genetic variants.
Read MoreCreating More Accurate Measurements of NSCLC Treatment Response
Droplet digital PCR is rapidly becoming an invaluable tool in cancer treatment research.
Read More